Cost-Utility Analysis of Atazanavir/Ritonavir 200/100 Mg Versus Atazanavir/Ritonavir 300/100 Mg in Thai Adults with Virologic Suppression

Authors :: T Worrathammasorn
Sasisopin Kiertiburanakul
Kiat Ruxrungtham
Ploenchan Chetchotisakd
Torsak Bunupuradah
Suthira Taychakhoonavudh
Sean Emery
P Hadnorntun
Anchalee Avihingsanon
N Maneesawangwong
Source :: Value in Health. 19:A912
Publication Year :: 2016
Publisher :: Elsevier BV, 2016.

Subjects :: medicine.medical_specialty
Cost–utility analysis
business.industry
Health Policy
Internal medicine
Public Health, Environmental and Occupational Health
Medicine
business
Gastroenterology
Atazanavir/ritonavir

Full Text Access

Tools